Evidence map›Paper›PMID 41703400›Full record

SynthesisJournal of foot and ankle research2026

Efficacy and Safety of Dextrose Prolotherapy Versus Corticosteroid Injections in Plantar Fasciitis: A Systematic Review and Meta-Analysis.

Ruaa Mustafa Qafesha, Hammam Anas Ishreiteh, Adli Luay Nassourah, Omar Islam Tawil, Doaa Mashaly

Abstract readSystematic ReviewMeta-AnalysisComparative Study
In one paragraph

Synthesis in Journal of foot and ankle research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ruaa Mustafa QafeshaDepartment of Human Anatomy and Embryology, Faculty of Medicine, Al-Quds University, Jerusalem, Palestine.ORCID https://orcid.org/0000-0002-8745-0260
Hammam Anas IshreitehFaculty of Medicine, Al-Quds University, Jerusalem, Palestine.ORCID https://orcid.org/0009-0008-8088-0322
Adli Luay NassourahMedical Research Group of Egypt, Negida Academy, Arlington, Massachusetts, USA.ORCID https://orcid.org/0009-0008-7905-7777
Omar Islam TawilFaculty of Medicine, Al-Quds University, Jerusalem, Palestine.ORCID https://orcid.org/0009-0004-5391-6693
Doaa MashalyFaculty of Medicine, October 6 University, 6th of October City, Egypt.ORCID https://orcid.org/0009-0009-4178-2874

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPlantar fasciitis (PF) is a common cause of heel pain that affects the health-related quality of life of many individuals and has various treatment options. Two effective interventions are corticosteroid (CS) injections and dextrose prolotherapy (DP). This study aimed to compare the efficacy and safety of DP and CS in patients with PF systematically.

methodsRelevant studies, including those comparing DP and CS for treating PF, were identified by searching electronic databases until August 2025. The visual analog scale (VAS) pain score, foot function index (FFI), and plantar fascia thickness (PFT) were compared between the groups in the short term (0.5-1 month) and mid-term (3 months). Statistical analyses were performed via RevMan 4.5.1, and p < 0.05 was considered statistically significant.

resultsFive RCTs and two cohort studies, with a total of 567 patients, were included in the meta-analysis. The analysis revealed that at the short-term follow-up (1 month), corticosteroid injections were more effective at reducing the VAS pain scores than dextrose prolotherapy for general VAS score (MD = 1.85, 95% CI [0.05, 3.64], p = 0.04), the VAS score at the first step in the morning (MD = 1.26, 95% CI [0.49, 2.02], p = 0.001), and the VAS score for pain while walking (MD = 1.85, 95% CI [0.68, 3.02], p = 0.002). Similarly, at the short-term follow-up (1 month), the analysis revealed a significantly greater reduction in the FFI score (MD = 18.81, 95% CI [0.06, 37.55]) and PFT (MD = 0.26 mm, 95% CI [0.07, 0.45]) in the CS group than in the DP group. At 3 months, the analysis revealed a significant decrease in the FFI score (p = 0.003) in the DP group compared with the CS group, whereas no significant difference was observed in the VAS scores or PFT.

conclusionIn patients with plantar fasciitis, CS injections had greater efficacy than DP did in the short term; however, their efficacy became similar in the mid-term follow-up, with DP outperforming CS in terms of foot function. Further trials with standardized protocols and long-term follow-ups are needed to address potential biases.

Indexed as

Adrenal Cortex HormonesFasciitis, PlantarGlucoseProlotherapyFemaleHumansInjectionsMaleMiddle AgedPain MeasurementTreatment OutcomeAdrenal Cortex HormonesGlucosecorticosteroid injectiondextrose prolotherapyfoot functionmeta‐analysispainplantar fascia thicknessplantar fasciitis

Identifiers

PMID41703400
PMCPMC12913222

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.